105 related articles for article (PubMed ID: 28420510)
1. Gene set-based analysis of mucinous ovarian carcinoma.
Chang CM; Wang PH; Horng HC
Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
[TBL] [Abstract][Full Text] [Related]
2. Gene set-based integrative analysis of ovarian clear cell carcinoma.
Chang CM; Chiou SH; Yang MJ; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):552-7. PubMed ID: 27590381
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract][Full Text] [Related]
4. The molecular origin and taxonomy of mucinous ovarian carcinoma.
Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Anglesio MS; Au-Yeung G; Böhm M; Bowtell DDL; Brand A; Chenevix-Trench G; Christie M; Chiew YE; Churchman M; DeFazio A; Demeo R; Dudley R; Fairweather N; Fedele CG; Fereday S; Fox SB; Gilks CB; Gourley C; Hacker NF; Hadley AM; Hendley J; Ho GY; Hughes S; Hunstman DG; Hunter SM; Jobling TW; Kalli KR; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Mes-Masson AM; Mileshkin L; Provencher DM; Pyman J; Rahimi K; Rowley SM; Salazar C; Samimi G; Saunders H; Semple T; Sharma R; Sharpe AJ; Stephens AN; Thio N; Torres MC; Traficante N; Xing Z; Zethoven M; Antill YC; Scott CL; Campbell IG; Gorringe KL
Nat Commun; 2019 Sep; 10(1):3935. PubMed ID: 31477716
[TBL] [Abstract][Full Text] [Related]
5. Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages.
Chang CM; Chuang CM; Wang ML; Yang MJ; Chang CC; Yen MS; Chiou SH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275818
[TBL] [Abstract][Full Text] [Related]
6. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options for mucinous ovarian carcinoma.
Gorringe KL; Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Bowtell DDL; Christie M; Chiew YE; Churchman M; DeFazio A; Fereday S; Gilks CB; Gourley C; Hadley AM; Hendley J; Hunter SM; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Pyman J; Rowley SM; Salazar C; Saunders H; Semple T; Stephens AN; Thio N; Torres MC; Traficante N; Zethoven M; Antill YC; Campbell IG; Scott CL
Gynecol Oncol; 2020 Mar; 156(3):552-560. PubMed ID: 31902686
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated immunological and metabolic functions discovered by a polygenic integrative analysis for PCOS.
Ho CH; Chang CM; Li HY; Shen HY; Lieu FK; Wang PS
Reprod Biomed Online; 2020 Jan; 40(1):160-167. PubMed ID: 31780352
[TBL] [Abstract][Full Text] [Related]
9. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
10. Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
[TBL] [Abstract][Full Text] [Related]
11. A distinct molecular profile associated with mucinous epithelial ovarian cancer.
Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry JP; Scolyer RA; Smith AN; Bali A; Vanden Bergh P; Baron-Hay S; Scott C; Fink D; Hacker NF; Sutherland RL; O'Brien PM
Br J Cancer; 2006 Mar; 94(6):904-13. PubMed ID: 16508639
[TBL] [Abstract][Full Text] [Related]
12. HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer.
Chao WR; Lee MY; Lin WL; Chen CK; Lin JC; Koo CL; Sheu GT; Han CP
Hum Pathol; 2014 Apr; 45(4):810-6. PubMed ID: 24656091
[TBL] [Abstract][Full Text] [Related]
13. Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
Liew PL; Huang RL; Weng YC; Fang CL; Hui-Ming Huang T; Lai HC
Int J Cancer; 2018 Jul; 143(2):355-367. PubMed ID: 29451304
[TBL] [Abstract][Full Text] [Related]
14. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
[TBL] [Abstract][Full Text] [Related]
15.
Hisamatsu T; McGuire M; Wu SY; Rupaimoole R; Pradeep S; Bayraktar E; Noh K; Hu W; Hansen JM; Lyons Y; Gharpure KM; Nagaraja AS; Mangala LS; Mitamura T; Rodriguez-Aguayo C; Eun YG; Rose J; Bartholomeusz G; Ivan C; Lee JS; Matsuo K; Frumovitz M; Wong KK; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2019 Jan; 18(1):162-172. PubMed ID: 30305341
[TBL] [Abstract][Full Text] [Related]
16. The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis.
Su KM; Lin TW; Liu LC; Yang YP; Wang ML; Tsai PH; Wang PH; Yu MH; Chang CM; Chang CC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316695
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
[TBL] [Abstract][Full Text] [Related]
18. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Kelemen LE; Earp M; Fridley BL; Chenevix-Trench G; ; Fasching PA; Beckmann MW; Ekici AB; Hein A; Lambrechts D; Lambrechts S; Van Nieuwenhuysen E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Behrens S; Moysich KB; Cannioto R; Lele S; Odunsi K; Goodman MT; Shvetsov YB; Thompson PJ; Wilkens LR; Dörk T; Antonenkova N; Bogdanova N; Hillemanns P; Runnebaum IB; du Bois A; Harter P; Heitz F; Schwaab I; Butzow R; Pelttari LM; Nevanlinna H; Modugno F; Edwards RP; Kelley JL; Ness RB; Karlan BY; Lester J; Orsulic S; Walsh C; Kjaer SK; Jensen A; Cunningham JM; Vierkant RA; Giles GG; Bruinsma F; Southey MC; Hildebrandt MAT; Liang D; Lu K; Wu X; Sellers TA; Levine DA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Tworoger SS; Poole EM; Bandera EV; Olson SH; Orlow I; Vestrheim Thomsen LC; Bjorge L; Krakstad C; Tangen IL; Kiemeney LA; Aben KKH; Massuger LFAG; van Altena AM; Pejovic T; Bean Y; Kellar M; Cook LS; Le ND; Brooks-Wilson A; Gronwald J; Cybulski C; Jakubowska A; Lubiński J; Wentzensen N; Brinton LA; Lissowska J; Hogdall E; Engelholm SA; Hogdall C; Lundvall L; Nedergaard L; Pharoah PDP; Dicks E; Song H; Tyrer JP; McNeish I; Siddiqui N; Carty K; Glasspool R; Paul J; Campbell IG; Eccles D; Whittemore AS; McGuire V; Rothstein JH; Sieh W; Narod SA; Phelan CM; McLaughlin JR; Risch HA; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Gentry-Maharaj A; Ramus SJ; Wu AH; Pearce CL; Lee AW; Pike MC; Kupryjanczyk J; Podgorska A; Plisiecka-Halasa J; Sawicki W; Goode EL; Berchuck A;
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134598
[TBL] [Abstract][Full Text] [Related]
19. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
20. Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.
Abobaker S; Kulbe H; Taube ET; Darb-Esfahani S; Richter R; Denkert C; Jank P; Sehouli J; Braicu EI
Anticancer Res; 2022 Apr; 42(4):1739-1747. PubMed ID: 35346992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
